iPSC-derived hindbrain organoids to evaluate escitalopram oxalate treatment responses targeting neuropsychiatric symptoms in Alzheimer’s disease

  1. Zivko, C.
  2. Sagar, R.
  3. Xydia, A.
  4. Lopez-Montes, A.
  5. Mintzer, J.
  6. Rosenberg, P.B.
  7. Shade, D.M.
  8. Porsteinsson, A.P.
  9. Lyketsos, C.G.
  10. Mahairaki, V.
Revue:
Molecular Psychiatry

ISSN: 1476-5578 1359-4184

Année de publication: 2024

Type: Article

DOI: 10.1038/S41380-024-02629-Y GOOGLE SCHOLAR lock_openAccès ouvert editor